Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

Name: Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
Published: 2010
License: Public Domain

Pfizer · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

arthritis autoimmune-diseases clinical-trial rheumatoid

arthritis, rheumatoid, oral jak inhibitor, mtx, dmard, clinical trial, joint diseases, autoimmune diseases, anti-inflammatory agents, rheumatic diseases, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

Related documents